Digital Therapeutics & Medical Devices for Migraine Market Size, Share & Trends Analysis Report By Type (Arm Device, Neck Device, Head/Forehead Device, and Others), By Age Group (Above 18 Years and Above 12 Years), By Mode of Action (Electrical Pulse, Mild Electrical Stimulation, and Deep Muscle Treatment), By Region, And By Segment Forecasts, 2024-2031
Digital Therapeutics & Medical Devices for Migraine Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2024-2031.
Digital therapeutics and medical devices for migraines describe interventions that use technology to alleviate and control migraine symptoms. Mindfulness exercises and cognitive behavioral therapy for migraine symptom management are common in digital treatments. Several factors contribute to the market growth in the coming years, such as developments in digital health technology, heightened migraine awareness and prevalence, and a rising desire for alternatives to pharmaceutical treatments. Further factors fueling market growth include the increasing availability of telemedicine services and the development of AI and ML-powered tailored healthcare solutions. In addition, digital therapeutics and medical devices for migraines are seeing increased use as digital health solutions become more acceptable and are used by patients and healthcare providers worldwide, driving market expansion.
However, digital therapeutics & medical devices for migraine market slow down the market growth due to various factors such as their high cost, challenges with regulations, expensive development and implementation, and worries over data safety and confidentiality. Moreover, the market is expected to experience growth throughout the forecast time period due to technological advancements, strong alliances with government agencies, a younger population, and an increase in healthcare expenditure.
Competitive Landscape
Some Major Key Players In The Digital Therapeutics & Medical Devices for Migraine Market:
- Relivion MG
- gammaCore
- WeatherX
- Aculief
- Theragun
- Allay Lamp
- Shakti Mat
- Allodynic Therapeutics, LLC
- Amgen Inc.
- Bayer AG
- Cefaly Technology
- Cirrus Healthcare Products
- electroCore, Inc
- Eli Lilly and Company
- eNeura Inc.
- GlaxoSmithKline plc.
- Neurolief Ltd.
- Neuros Medical, Inc.
- Novartis AG
- Pfizer Inc.
- Salvia BioElectronics B.V.
- Theranica Bio-Electronics Ltd.
- Other Prominent Players
Market Segmentation:
The digital therapeutics & medical devices for migraine market is segmented based on type, age group, and mode of action. Based on type, the market is segmented into arm devices, neck devices, head/forehead devices, and others. By age group, the market is segmented into those above 18 years and those above 12 years. By mode of action, the market is segmented into electrical pulse, mild electrical stimulation, and deep muscle treatment.
Based On Type, The Head/Forehead Device Segment Is Accounted As A Major Contributor In The Digital Therapeutics & Medical Devices For Migraine Market.
The head/forehead device category will hold a major share of the global digital therapeutics & medical devices for migraine market in 2023. This is because of the straightforward way they relieve migraine symptoms. These gadgets offer a non-invasive and drug-free solution by utilizing monitoring techniques. They are becoming popular as an alternative to standard pharmaceutical therapies due to their efficacy and user-friendliness, driving market expansion.
The Above 18 Years Segment Witnessed Growth At A Rapid Rate.
The above 18 years segment is projected to grow rapidly in the global digital therapeutics & medical devices for migraine market because migraines frequently strike adults. Due to the desire to avoid drug usage and keep productivity high, more and more adults are looking for effective non-pharmacological ways to control migraines. This is especially true among working-age adults. The increasing knowledge and willingness of this demographic to embrace digital health solutions also contribute to the segment’s growth in the future.
In The Region, The North American Digital Therapeutics & Medical Devices For Migraine Market Holds A Significant Revenue Share.
The North American digital therapeutics & medical devices for migraine market is expected to record the maximum market share in revenue in the near future. The region is propelled because of the substantial investment in healthcare technology, the widespread use of digital health solutions, and the well-developed healthcare infrastructure. In addition, the Asia Pacific region’s market is anticipated to experience expansion in the global market for digital therapeutics & medical devices for migraine due to the region’s rising healthcare spending and emphasis on research and innovation on non-pharmacological therapies for migraines. In addition, the Asia Pacific region is likely to experience industrial expansion because of the rising cost of healthcare, the incidence of migraine problems, and the growing interest in digital health solutions. This trend is further accelerated by the development of new technologies and the growth of healthcare infrastructure, which drives the market growth in this area.
Recent Developments:
- In January 2024, Neurolief is delighted to announce that Sawai Group Holdings Co., Ltd. made a strategic equity investment. An exclusive agreement was previously inked for the development and marketing of Neurolief’sRelivion, a groundbreaking non-invasive, at-home wearable electroceutical therapy for depression and migraines, in Japan. This investment further strengthens the strategic collaboration between Neurolief and the Japanese pharmaceutical corporation.
- In February 2024, Theranica, a leader in prescribed digital therapeutics, has announced that its Nerivio Remote Electrical Neuromodulation wearable, designed for the treatment and prevention of migraines, will be covered by a commercial insurance policy offered by Highmark Inc.
Digital Therapeutics & Medical Devices for Migraine Market Report Scope
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 8.6% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, Age Group, And Mode Of Action |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
| Competitive Landscape | Relivion MG, gammaCore, WeatherX, Aculief, Theragun, Allay Lamp, Allodynic Therapeutics, LLC, Amgen Inc., Bayer AG, Cefaly Technology, Cirrus Healthcare Products, electroCore, Inc, Eli Lilly and Company, eNeura Inc., GlaxoSmithKline plc., Neurolief Ltd., Neuros Medical, Inc., Novartis AG, Pfizer Inc., Salvia BioElectronics B.V., and Theranica Bio-Electronics Ltd., and other market players. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Digital Therapeutics & Medical Devices for Migraine Market-
Digital Therapeutics & Medical Devices for Migraine Market By Type-
- Arm Device
- Neck Device
- Head/Forehead Device
- Others
Digital Therapeutics & Medical Devices for Migraine Market By Age-Group-
- Above 18 Years
- Above 12 Years
Digital Therapeutics & Medical Devices for Migraine Market By Mode of Action-
- Electrical Pulse
- Mild Electrical Stimulation
- Deep Muscle Treatment
Digital Therapeutics & Medical Devices for Migraine Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Digital Therapeutics & Medical Devices for Migraine Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2024-2031.
GlaxoSmithKline plc., Neurolief Ltd., Neuros Medical, Inc., Novartis AG, Pfizer Inc., Salvia BioElectronics B.V., and Theranica Bio-Electronics Ltd.,